Demographics (2)
- AGE - Subject age at enrollment (phv00556760.v1.p1)
- SEX - Biological sex (phv00556755.v1.p1)
Disease Events (1)
- IS_TUMOR - Tumor status (phv00556766.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00556759.v1.p1)
Other (13)
- ANALYTE_TYPE - Analyte type (phv00556765.v1.p1)
- BEST_THERAPEUTIC_RESPONSE_METASTATIC - Response to therapy metastatic cohort (phv00556762.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00556764.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body. (phv00556754.v1.p1)
- PATHOLOGIC_STAGE_ADJUVANT - Pathological stage for adjuvant cohort (phv00556769.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor or metastasis if applicable (phv00556767.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location if applicable (phv00556768.v1.p1)
- SAMPLE_ID - Sample ID (phv00556763.v1.p1)
- SAMPLE_ID - Sample ID (phv00556757.v1.p1)
- SUBJECT_ID - Subject ID (phv00556758.v1.p1)
- SUBJECT_ID - Subject ID (phv00556753.v1.p1)
- SUBJECT_ID - Subject ID (phv00556756.v1.p1)
- THERAPEUTIC_RESPONSE_ADJUVANT - Response to therapy adjuvant cohort (phv00556761.v1.p1)